Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure

Hyman J. Zimmerman, Willis C. Maddrey

Research output: Contribution to journalArticle

369 Citations (Scopus)

Abstract

Hepatic injury in alcoholics due to intake of acetaminophen (APAP or acetylparaaminophenol) with therapeutic intent has been reported, but the extent of the phenomenon is not clear, pertinent details of the association remain insufficiently clarified, and the importance of the phenomenon is not widely appreciated. The present report describes 67 patients who developed hepatic injury after ingestion of APAP with therapeutic intent. All were regular users of alcohol. Sixty-four percent of the patients were considered to be "alcoholic" or reported intakes greater than 80 g/d, 35% took 60 g/d or less, and the remainder were vague in their reporting. Doses of APAP were in the "nontoxic" range (<6 g/d) in 60% of the group, within the recommended range (<4 g/ d) in 40%, and at 4.1 to 6 g/d in 20%. Characteristic feature was the towering level reached by aspartate transaminase (AST) with figures ranging from 3,000 to 48,000 IU in more than 90% of cases. Almost 20% of the patients died. The data on these patients were similar to 94 cases of injury from APAP taken with therapeutic intent reported in the literature. This study provides further evidence of hepatic injury in regular users of alcohol, especially chronic alcoholics, who take APAP with therapeutic intent. Susceptibility is presumably caused by induction of cytochrome P-4502EI by ethanol and by depletion of glutathione (GSH) because of the effects of alcohol, the malnutrition often associated with alcoholism, and the depletion associated with chronic use of APAP and impaired glucuronidation caused by fasting perhaps as well. The syndrome of liver injury is distinctive, marked by uniquely elevated levels of AST, and poses a significant threat. A greater awareness of the phenomenon by the medical and lay community is essential.

Original languageEnglish (US)
Pages (from-to)767-773
Number of pages7
JournalHepatology
Volume22
Issue number3
DOIs
StatePublished - 1995

Fingerprint

Acetaminophen
Alcohols
Wounds and Injuries
Liver
Alcoholics
Aspartate Aminotransferases
Therapeutics
Cytochromes
Malnutrition
Alcoholism
Glutathione
Fasting
Ethanol
Eating

ASJC Scopus subject areas

  • Hepatology

Cite this

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol : Analysis of instances of therapeutic misadventure. / Zimmerman, Hyman J.; Maddrey, Willis C.

In: Hepatology, Vol. 22, No. 3, 1995, p. 767-773.

Research output: Contribution to journalArticle

@article{a7d8c46b331d473d843e63fe3a13d82d,
title = "Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure",
abstract = "Hepatic injury in alcoholics due to intake of acetaminophen (APAP or acetylparaaminophenol) with therapeutic intent has been reported, but the extent of the phenomenon is not clear, pertinent details of the association remain insufficiently clarified, and the importance of the phenomenon is not widely appreciated. The present report describes 67 patients who developed hepatic injury after ingestion of APAP with therapeutic intent. All were regular users of alcohol. Sixty-four percent of the patients were considered to be {"}alcoholic{"} or reported intakes greater than 80 g/d, 35{\%} took 60 g/d or less, and the remainder were vague in their reporting. Doses of APAP were in the {"}nontoxic{"} range (<6 g/d) in 60{\%} of the group, within the recommended range (<4 g/ d) in 40{\%}, and at 4.1 to 6 g/d in 20{\%}. Characteristic feature was the towering level reached by aspartate transaminase (AST) with figures ranging from 3,000 to 48,000 IU in more than 90{\%} of cases. Almost 20{\%} of the patients died. The data on these patients were similar to 94 cases of injury from APAP taken with therapeutic intent reported in the literature. This study provides further evidence of hepatic injury in regular users of alcohol, especially chronic alcoholics, who take APAP with therapeutic intent. Susceptibility is presumably caused by induction of cytochrome P-4502EI by ethanol and by depletion of glutathione (GSH) because of the effects of alcohol, the malnutrition often associated with alcoholism, and the depletion associated with chronic use of APAP and impaired glucuronidation caused by fasting perhaps as well. The syndrome of liver injury is distinctive, marked by uniquely elevated levels of AST, and poses a significant threat. A greater awareness of the phenomenon by the medical and lay community is essential.",
author = "Zimmerman, {Hyman J.} and Maddrey, {Willis C.}",
year = "1995",
doi = "10.1016/0270-9139(95)90295-3",
language = "English (US)",
volume = "22",
pages = "767--773",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "3",

}

TY - JOUR

T1 - Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol

T2 - Analysis of instances of therapeutic misadventure

AU - Zimmerman, Hyman J.

AU - Maddrey, Willis C.

PY - 1995

Y1 - 1995

N2 - Hepatic injury in alcoholics due to intake of acetaminophen (APAP or acetylparaaminophenol) with therapeutic intent has been reported, but the extent of the phenomenon is not clear, pertinent details of the association remain insufficiently clarified, and the importance of the phenomenon is not widely appreciated. The present report describes 67 patients who developed hepatic injury after ingestion of APAP with therapeutic intent. All were regular users of alcohol. Sixty-four percent of the patients were considered to be "alcoholic" or reported intakes greater than 80 g/d, 35% took 60 g/d or less, and the remainder were vague in their reporting. Doses of APAP were in the "nontoxic" range (<6 g/d) in 60% of the group, within the recommended range (<4 g/ d) in 40%, and at 4.1 to 6 g/d in 20%. Characteristic feature was the towering level reached by aspartate transaminase (AST) with figures ranging from 3,000 to 48,000 IU in more than 90% of cases. Almost 20% of the patients died. The data on these patients were similar to 94 cases of injury from APAP taken with therapeutic intent reported in the literature. This study provides further evidence of hepatic injury in regular users of alcohol, especially chronic alcoholics, who take APAP with therapeutic intent. Susceptibility is presumably caused by induction of cytochrome P-4502EI by ethanol and by depletion of glutathione (GSH) because of the effects of alcohol, the malnutrition often associated with alcoholism, and the depletion associated with chronic use of APAP and impaired glucuronidation caused by fasting perhaps as well. The syndrome of liver injury is distinctive, marked by uniquely elevated levels of AST, and poses a significant threat. A greater awareness of the phenomenon by the medical and lay community is essential.

AB - Hepatic injury in alcoholics due to intake of acetaminophen (APAP or acetylparaaminophenol) with therapeutic intent has been reported, but the extent of the phenomenon is not clear, pertinent details of the association remain insufficiently clarified, and the importance of the phenomenon is not widely appreciated. The present report describes 67 patients who developed hepatic injury after ingestion of APAP with therapeutic intent. All were regular users of alcohol. Sixty-four percent of the patients were considered to be "alcoholic" or reported intakes greater than 80 g/d, 35% took 60 g/d or less, and the remainder were vague in their reporting. Doses of APAP were in the "nontoxic" range (<6 g/d) in 60% of the group, within the recommended range (<4 g/ d) in 40%, and at 4.1 to 6 g/d in 20%. Characteristic feature was the towering level reached by aspartate transaminase (AST) with figures ranging from 3,000 to 48,000 IU in more than 90% of cases. Almost 20% of the patients died. The data on these patients were similar to 94 cases of injury from APAP taken with therapeutic intent reported in the literature. This study provides further evidence of hepatic injury in regular users of alcohol, especially chronic alcoholics, who take APAP with therapeutic intent. Susceptibility is presumably caused by induction of cytochrome P-4502EI by ethanol and by depletion of glutathione (GSH) because of the effects of alcohol, the malnutrition often associated with alcoholism, and the depletion associated with chronic use of APAP and impaired glucuronidation caused by fasting perhaps as well. The syndrome of liver injury is distinctive, marked by uniquely elevated levels of AST, and poses a significant threat. A greater awareness of the phenomenon by the medical and lay community is essential.

UR - http://www.scopus.com/inward/record.url?scp=0029083319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029083319&partnerID=8YFLogxK

U2 - 10.1016/0270-9139(95)90295-3

DO - 10.1016/0270-9139(95)90295-3

M3 - Article

C2 - 7657281

AN - SCOPUS:0029083319

VL - 22

SP - 767

EP - 773

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 3

ER -